Ka
Non vérifié

Kardigan

Ce que nous écrivons

BiotechnologieCardiologieIndustrieIndustrie pharmaceutiqueSanté
14/10/2025
Biotechnologie
Industrie pharmaceutique
Santé
Cardiologie
Industrie
Kardigan Raises $254 Million Series B to Advance Late-Stage Portfolio of Personalized Cardiovascular Medicines
1.00
29/09/2025
Événements
Industrie
Santé
Médecine - Divers
Industrie pharmaceutique
Cardiologie
Biotechnologie
Kardigan Announces Presentation of Positive Phase 2a Data for Danicamtiv in Patients with Dilated Cardiomyopathy at HFSA Annual Scientific Meeting 2025
1.00
25/09/2025
Industrie
Santé
Médecine - Divers
Industrie pharmaceutique
Cardiologie
Biotechnologie
Kardigan Advances Late-Stage Portfolio of Personalized Cardiovascular Medicines in Dilated Cardiomyopathy, Acute Severe Hypertension and Calcific Aortic Valve Stenosis
1.00
27/03/2025
Multimédia
Marché financier
Santé
Technique
Logiciels
Industrie pharmaceutique
Cardiologie
Biotechnologie
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform
1.00
10/01/2025
Marché du travail
Science
Cardiologie
Biotechnologie
Industrie pharmaceutique
Santé
Associations/Professionnels
Kardigan Launches with Industry-Leading Team to Modernize Cardiovascular Drug Development with Late-Stage Portfolio of Personalized Medicines
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0